National Health Service Blood and Transplant (NHSBT), Southampton, United Kingdom.
Rodekruis Blood Service, Edegem, Belgium.
Blood Transfus. 2014 Jan;12(1):91-8. doi: 10.2450/2013.0208-13. Epub 2013 Dec 11.
The assessment of suppliers of critical goods and services to European blood establishments is a regulatory requirement proving difficult to resource. This study was to establish whether European Blood Alliance member blood services could collaborate to reduce the cost of auditing suppliers without diminishing standards.
Five blood services took part, each contributing a maximum of one qualified auditor per audit (rather than the usual two). Four audits were completed involving eight auditors in total to a European Blood Alliance agreed policy and process using an audit scope agreed with suppliers.
Audits produced a total of 22 observations, the majority relating to good manufacturing practice and highlighted deficiencies in processes, procedures and quality records including complaints' handling, product recall, equipment calibration, management of change, facilities' maintenance and monitoring and business continuity. Auditors reported that audits had been useful to their service and all audits prompted a positive response from suppliers with satisfactory corrective action plans where applicable. Audit costs totalled € 3,438 (average € 860 per audit) which is no more than equivalent traditional audits. The four audit reports have been shared amongst the five participating blood establishments and benefitted 13 recipient departments in total. Previously, 13 separate audits would have been required by the five blood services.
Collaborative supplier audit has proven an effective and efficient initiative that can reduce the resource requirements of both suppliers and individual blood service's auditing costs. Collaborative supplier audit has since been established within routine European Blood Alliance management practice.
评估向欧洲血站供应关键物资和服务的供应商是一项监管要求,在资源方面颇具难度。本研究旨在确定欧洲血盟成员血站能否合作,在不降低标准的情况下降低供应商审核成本。
共有 5 家血站参与,每家血站在每次审核中最多派遣一名合格审核员(而不是通常的 2 名)。总共完成了 4 次审核,总计 8 名审核员,按照欧洲血盟商定的政策和程序进行,使用与供应商商定的审核范围。
审核共产生 22 条意见,其中大部分涉及良好生产规范,并突出了流程、程序和质量记录方面的缺陷,包括投诉处理、产品召回、设备校准、变更管理、设施维护和监测以及业务连续性。审核员报告称,审核对其服务很有帮助,所有审核都得到了供应商的积极响应,在适用的情况下提供了满意的纠正行动计划。审核费用总计 3438 欧元(每次审核平均 860 欧元),与传统审核费用相当。这 4 份审核报告已在 5 家参与血站之间共享,总共惠及 13 个受援部门。在此之前,5 家血站各自需要进行 13 次单独的审核。
协作供应商审核已被证明是一种有效且高效的举措,可以降低供应商和单个血站审核成本的资源需求。协作供应商审核现已成为欧洲血盟常规管理实践的一部分。